MPCI structure
|
Common Name | MPCI | ||
|---|---|---|---|---|
| CAS Number | 884538-31-2 | Molecular Weight | 519.45 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H32BrFN4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MPCIMPCI is a selective melanocortin-4 receptor antagonist. |
| Name | MPCI |
|---|
| Description | MPCI is a selective melanocortin-4 receptor antagonist. |
|---|---|
| References | 1. Sayre EC, Guermazi A, Esdaile JM, Kopec JA, Singer J, Thorne A, Nicolaou S, Cibere J. Associations between MRI features versus knee pain severity and progression: Data from the Vancouver Longitudinal Study of Early Knee Osteoarthritis. PLoS One. 2017 May 4;12(5):e0176833. doi: 10.1371/journal.pone.0176833. eCollection 2017. PubMed PMID: 28472071; PubMed Central PMCID: PMC5417516. |
| Molecular Formula | C25H32BrFN4O2 |
|---|---|
| Molecular Weight | 519.45 |
| InChIKey | AMXJMRXFZPRCQM-UHFFFAOYSA-N |
| SMILES | CCN1CCC(CN=C(N)NC(=O)c2cccc(F)c2CCc2cc(Br)ccc2OC)CC1 |